These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9198229)

  • 1. The Leiden Thrombophilia Study (LETS).
    van der Meer FJ; Koster T; Vandenbroucke JP; Briët E; Rosendaal FR
    Thromb Haemost; 1997 Jul; 78(1):631-5. PubMed ID: 9198229
    [No Abstract]   [Full Text] [Related]  

  • 2. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
    Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F
    Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of venous thromboembolism in families with inherited thrombophilia.
    Simioni P; Sanson BJ; Prandoni P; Tormene D; Friederich PW; Girolami B; Gavasso S; Huisman MV; Büller HR; Wouter ten Cate J; Girolami A; Prins MH
    Thromb Haemost; 1999 Feb; 81(2):198-202. PubMed ID: 10063991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism.
    Andersen BS; Olsen J; Nielsen GL; Steffensen FH; Sørensen HT; Baech J; Gregersen H
    Thromb Haemost; 1998 Jan; 79(1):28-31. PubMed ID: 9459317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary deficiencies of antithrombin III, protein S, and the protein C pathway in Jordanian thrombosis patients.
    Eid SS
    Clin Lab Sci; 2002; 15(4):196-9. PubMed ID: 12776777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inherited thrombophilia and arterial diseases].
    Robert-Ebadi H; Boehlen F; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):331-2, 334-5. PubMed ID: 17370730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K; Svensson PJ; Ohlin AK
    Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S.
    De Stefano V; Simioni P; Rossi E; Tormene D; Za T; Pagnan A; Leone G
    Haematologica; 2006 May; 91(5):695-8. PubMed ID: 16670075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors.
    Pabinger I; Schneider B
    Thromb Haemost; 1994 May; 71(5):548-52. PubMed ID: 8091378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism.
    Okumus G; Kiyan E; Arseven O; Tabak L; Diz-Kucukkaya R; Unlucerci Y; Abaci N; Unaltuna NE; Issever H
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):168-73. PubMed ID: 17895505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombophilia caused by congenital disorders of blood coagulation].
    Hiller E; Pihusch R
    Fortschr Med; 1998 Oct; 116(29):26-8, 30, 32 passim. PubMed ID: 9846471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.